Medicine information
Uses & overview
R.S. IPRATROP 1.25 contains Levosalbutamol and Ipratropium Bromide, a combination of bronchodilators used for the management of certain respiratory conditions involving airway narrowing and breathing difficulty, as prescribed by a healthcare professional. Levosalbutamol is a short-acting bronchodilator that helps relax the muscles surrounding the airways, helping improve airflow. Ipratropium Bromide is an anticholinergic bronchodilator that helps reduce airway constriction and supports easier breathing. R.S. IPRATROP 1.25 is administered using a suitable nebuliser and should be used according to the dose and frequency recommended by your doctor. The combination is designed to provide bronchodilation and help manage symptoms such as wheezing, chest tightness, and shortness of breath associated with airway obstruction. This medicine should be used as prescribed and is not a substitute for emergency medical care when severe or rapidly worsening breathing difficulty occurs.
How to use
Use R.S. IPRATROP 1.25 exactly as directed by your doctor or healthcare professional. It is intended for nebulisation and should not be swallowed or injected. Measure the prescribed quantity and place it into the nebuliser chamber. Use a suitable nebuliser according to the manufacturer's instructions. Sit comfortably and breathe normally through the mouthpiece or mask until the treatment is complete. If using a face mask, ensure it fits properly and avoid contact of the solution with the eyes. Clean the nebuliser after use according to the device manufacturer's instructions. Do not increase the dose or frequency without medical advice.
Storage
Store R.S. IPRATROP 1.25 according to the storage conditions stated on the product packaging. Keep the container in its original packaging and protect it from excessive heat and direct sunlight. Keep out of reach of children. Do not use after the expiry date or if the container is damaged or the solution appears abnormal.
